233 related articles for article (PubMed ID: 12703158)
1. [Influence of estrogen replacement therapy on atherogenic profile in postmenopausal women].
Alfonso Cano C; Vez García MD; García Urruticoechea P; Tornel Osorio PL; Canteras Jordana M; Abellán Alemán J
An Med Interna; 2003 Feb; 20(2):70-4. PubMed ID: 12703158
[TBL] [Abstract][Full Text] [Related]
2. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C
Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
[TBL] [Abstract][Full Text] [Related]
3. Effect of postmenopause and hormone replacement therapy on serum adiponectin levels.
Sieminska L; Wojciechowska C; Niedziolka D; Marek B; Kos-Kudla B; Kajdaniuk D; Nowak M
Metabolism; 2005 Dec; 54(12):1610-4. PubMed ID: 16311093
[TBL] [Abstract][Full Text] [Related]
4. Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women.
Bingol B; Gunenc Z; Yilmaz M; Biri A; Tiras B; Güner H
Arch Gynecol Obstet; 2010 May; 281(5):857-64. PubMed ID: 19593578
[TBL] [Abstract][Full Text] [Related]
5. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
Araújo DA; Farias ML; Andrade AT
Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
Chiantera V; Sarti CD; Fornaro F; Farzati A; De Franciscis P; Sepe E; Borrelli AL; Colacurci N
Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
[TBL] [Abstract][Full Text] [Related]
7. Short-term results of transdermal estrogen replacement therapy in cardiovascular disease-free postmenopausal females with and without hypertension.
Modena MG; Rossi R; Muia N; Origliani G; Rombolà O; Molinari R
G Ital Cardiol; 1998 Jun; 28(6):636-44. PubMed ID: 9672776
[TBL] [Abstract][Full Text] [Related]
8. Plasma adiponectin levels in postmenopausal women with or without long-term hormone therapy.
Im JA; Lee JW; Lee HR; Lee DC
Maturitas; 2006 Apr; 54(1):65-71. PubMed ID: 16198517
[TBL] [Abstract][Full Text] [Related]
9. [Changes of nitric oxide and endothelin plasma levels and effects of hormone replacement therapy in postmenopausal women].
Lai A; Zhang J; Ding L
Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):222-4. PubMed ID: 11776165
[TBL] [Abstract][Full Text] [Related]
10. Effects of postmenopausal hormone replacement therapy on body fat composition.
Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
[TBL] [Abstract][Full Text] [Related]
11. The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women.
D'Anna R; Baviera G; Corrado F; Cancellieri F; Crisafulli A; Squadrito F
Acta Obstet Gynecol Scand; 2005 May; 84(5):474-7. PubMed ID: 15842212
[TBL] [Abstract][Full Text] [Related]
12. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
13. Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors.
Wilcox JG; Hatch IE; Gentzschein E; Stanczyk FZ; Lobo RA
Fertil Steril; 1997 Feb; 67(2):273-7. PubMed ID: 9022602
[TBL] [Abstract][Full Text] [Related]
14. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
[TBL] [Abstract][Full Text] [Related]
15. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
[TBL] [Abstract][Full Text] [Related]
16. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
[TBL] [Abstract][Full Text] [Related]
17. Associations of postmenopausal hormone therapy with markers of hemostasis and inflammation and lipid profiles in diabetic and nondiabetic american Indian women: the strong heart study.
Zhang Y; Howard BV; Cowan LD; Welty TK; Schaefer CF; Wild RA; Yeh J; Lee ET
J Womens Health (Larchmt); 2004 Mar; 13(2):155-63. PubMed ID: 15072729
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk assessment with oxidised LDL measurement in postmenopausal women receiving intranasal estrogen replacement therapy.
Kurdoglu M; Yildirim M; Kurdoglu Z; Erdem A; Erdem M; Bilgihan A; Goktas B
Gynecol Endocrinol; 2011 Aug; 27(8):551-7. PubMed ID: 20670096
[TBL] [Abstract][Full Text] [Related]
19. [Effect of hormone replacement therapy on homocysteine and echocardiography in postmenopausal women].
Hui Y; Wu Y; Xiao L; Tang Z; Wu Y; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2002 Oct; 37(10):598-600. PubMed ID: 12487933
[TBL] [Abstract][Full Text] [Related]
20. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome.
Chu MC; Cosper P; Nakhuda GS; Lobo RA
Fertil Steril; 2006 Dec; 86(6):1669-75. PubMed ID: 17074346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
